Results 251 to 260 of about 119,963 (298)
Health-Related Quality of Life Following Treatment for Testicular Cancer: A Qualitative Systematic Review. [PDF]
Am J Mens HealthFox L +7 more
europepmc +1 more source
Editorial Comment on Survivorship Postretroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: A Systematic Review. [PDF]
Int J UrolMac Curtain BM.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Oncology, 2004
The purpose of this article is to review the recent clinically relevant literature on testicular cancer.Recent studies suggest that an increased incidence of testicular cancer is due to a birth-cohort effect and secondary to early exposure. Work on identifying tumor prognostic characteristics suggests that proliferation and apoptosis markers as well as
Gary R, MacVicar, Kenneth J, Pienta
+7 more sources
The purpose of this article is to review the recent clinically relevant literature on testicular cancer.Recent studies suggest that an increased incidence of testicular cancer is due to a birth-cohort effect and secondary to early exposure. Work on identifying tumor prognostic characteristics suggests that proliferation and apoptosis markers as well as
Gary R, MacVicar, Kenneth J, Pienta
+7 more sources
Nature Reviews Disease Primers, 2018
Testicular cancer is the most common malignancy among men between 14 and 44 years of age, and its incidence has risen over the past two decades in Western countries. Both genetic and environmental factors contribute to the development of testicular cancer, for which cryptorchidism is the most common risk factor.
Cheng, Liang +6 more
+7 more sources
Testicular cancer is the most common malignancy among men between 14 and 44 years of age, and its incidence has risen over the past two decades in Western countries. Both genetic and environmental factors contribute to the development of testicular cancer, for which cryptorchidism is the most common risk factor.
Cheng, Liang +6 more
+7 more sources
Current Opinion in Oncology, 1990
The human genome project has revolutionized technology for the study of DNA. Several of this year's papers have applied these techniques to the study of testicular cancer, especially the use of double-fluorescence in situ hybridization to identify the germ cell tumor marker isochrome 12p in tissue sections, and loss-of-heterozygosity studies to ...
openaire +8 more sources
The human genome project has revolutionized technology for the study of DNA. Several of this year's papers have applied these techniques to the study of testicular cancer, especially the use of double-fluorescence in situ hybridization to identify the germ cell tumor marker isochrome 12p in tissue sections, and loss-of-heterozygosity studies to ...
openaire +8 more sources
Current Opinion in Oncology, 2002
Testicular cancer remains a major success story in the realm of solid tumors. Although testicular cancer is highly treatable and curable, there are still many young men who succumb to the disease. Over the past year, important data regarding the diagnosis, treatment, and prognosis of testicular cancer have been reported. The significance of genetic and
Beth A, Hellerstedt, Kenneth J, Pienta
openaire +3 more sources
Testicular cancer remains a major success story in the realm of solid tumors. Although testicular cancer is highly treatable and curable, there are still many young men who succumb to the disease. Over the past year, important data regarding the diagnosis, treatment, and prognosis of testicular cancer have been reported. The significance of genetic and
Beth A, Hellerstedt, Kenneth J, Pienta
openaire +3 more sources
British Journal of Nursing, 1996
Around 1500 British men each year will develop testicular cancer (Imperial Cancer Research Fund, 1992). Although rare, testicular cancer is the most common form of cancer seen in men between the ages of 15 and 49 years, particularly the under 35 age group (Souhami and Tobias, 1995).
C, Bassett, R, McSherry
openaire +2 more sources
Around 1500 British men each year will develop testicular cancer (Imperial Cancer Research Fund, 1992). Although rare, testicular cancer is the most common form of cancer seen in men between the ages of 15 and 49 years, particularly the under 35 age group (Souhami and Tobias, 1995).
C, Bassett, R, McSherry
openaire +2 more sources
Current Problems in Cancer, 1998
The following article provides a comprehensive review of male germ cell tumors; the pathology and the clinical manifestations of the tumors are discussed, as are the modern concepts of clinical staging. Patients with bulky stage II and stage III non-seminomatous germ cell tumors are treated with chemotherapy. The new international classification system
openaire +2 more sources
The following article provides a comprehensive review of male germ cell tumors; the pathology and the clinical manifestations of the tumors are discussed, as are the modern concepts of clinical staging. Patients with bulky stage II and stage III non-seminomatous germ cell tumors are treated with chemotherapy. The new international classification system
openaire +2 more sources
Guidelines on Testicular Cancer
European Urology, 2005To up-date the 2001 version of the EAU testicular cancer guidelines.A non-structured literature review until January 2005 using the MEDLINE database has been performed. Literature has been classified according to evidence-based medicine levels.Testicular cancer is a highly curable disease.
Albers, Peter +8 more
openaire +2 more sources
Nursing
Abstract: Testicular cancer (TC) is the most prevalent malignancy in males ages 15 to 35. The incidence of TC is increasing among Hispanic males, which may indicate problems accessing care and the need to amplify the importance of TC awareness, early diagnosis, and prompt treatment.
Richard L, Pullen, Kenadee N, Canada
openaire +4 more sources
Abstract: Testicular cancer (TC) is the most prevalent malignancy in males ages 15 to 35. The incidence of TC is increasing among Hispanic males, which may indicate problems accessing care and the need to amplify the importance of TC awareness, early diagnosis, and prompt treatment.
Richard L, Pullen, Kenadee N, Canada
openaire +4 more sources